EGFR and cancer: EGFR, also known as HER1 and ErbB1, has received much attention as a marker, growth driver, and therapeutic target for cancers (Nicholson et al., 2001; Ciardiello and Tortora, 2008; Xu et al., 2017; Sigismund et al., 2018).